- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
A Closer Look at Carestream's Lux 35 Detector
The portability and durability of the device may make it an emerging option for bedside imaging.
Offering an array of promising benefits including quality imaging, usability across devices and enhanced portability due to lighter weight and an ergonomic design, Carestream’s Lux 35 Detector appears to check off a number of boxes for busy radiologists.
In a recent interview at RSNA 2021, Diagnostic Imaging sat down with Jill Hamman, the global product marketing manager for X-ray solutions for Carestream, to discuss the advantages of the Lux 35 Detector. Watch below:
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
